Enzymatic HbA1c Test Assists in Diagnosing and Monitoring Diabetes
The Atellica CH Enzymatic Hemoglobin A1c assay can be integrated onto chemistry testing platforms.
Read MorePosted by Chaunie Brusie | Jul 7, 2019 | Point-of-Care |
The Atellica CH Enzymatic Hemoglobin A1c assay can be integrated onto chemistry testing platforms.
Read MorePosted by Chaunie Brusie | May 16, 2019 | Research |
The findings emphasize the need for enhanced efforts to address the growing burden of liver cancer among lower socioeconomic groups.
Read MorePosted by Melissa Mayer | Oct 15, 2018 | Research |
Analysis of comprehensive biomarker profiles of Mexico City Prospective Study blood samples may provide insight into the ethnic and socioeconomic differences that underlie disease risk.
Read MorePosted by Melissa Mayer | Jul 27, 2018 | Heart Disease, Research |
Published findings show initial testing for three specific biomarkers may provide superior results over standard screening methods.
Read MorePosted by Steve Halasey | Jul 20, 2018 | Diagnostic Technologies |
Genomic testing underlies the company’s plans to reverse or prevent obesity and type 2 diabetes without medication or surgery.
Read More